Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Oncolytic Virotherapy
Interventions: BIOLOGICAL: Double Recombinant Vaccinia Virus VV-GMCSF-Lact
Sponsor: "Oncostar" LLC
Collaborators: N.N. Petrov National Medical Research Center of Oncology